Free preview
MD Pharmacology NMC syllabus ~5 min read Recent advances last updated on 2026-06-20

Antiviral Drugs (Non-retroviral)

Influenza, Herpes & Hepatitis — Targets, Agents, Resistance & Recent Advances

Past RGUHS + DNB + MPMSU + MUHS · 11 RGUHSDec '23 RGUHSJul '23 RGUHSNov '21 RGUHSMay '19 MUHSSummer '18 DNBDec '15 RGUHSOct '10 RGUHSApr '08 RGUHSSep '07 MPMSU2006 MPMSU2004

Introduction

  • Antiviral drugs act on viruses — obligate intracellular parasites that hijack host machinery. Selective toxicity is possible because virus-directed enzymes (distinct from host enzymes) can be targeted, sparing the host cell.
  • Most agents are virustatic — active only against replicating virus, not latent virus; they block a defined step of the replication cycle.
  • Because viral replication often peaks before symptoms appear, antivirals are most effective when started early (prophylactic / pre-emptive) — a key clinical limitation.
  • Acyclovir (Elion) is the prototype that launched the field; this topic covers non-retroviral agents only — anti-herpes, anti-influenza and anti-hepatitis (HIV/retroviruses are covered separately).
Continue reading

Antiviral Drugs Nonretroviral

PharmaNotes Pro · LAQ

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.